In vitro and in vivo characterization of pharmaceutical nanocarriers used for drug delivery

Abstract

Nanotechnology has emerged strongly in most of the field of sciences at a tiny scale. At this size, atoms and molecules work differently and present a diversity of amazing and appealing applications. Pharmaceutical nanocarriers comprise nanoparticles, nanospheres, nanocapsules, nanoemulsion, nanoliposomes and nanoniosomes. The major objectives in designing nanocarriers are to manage particle size, surface properties as well as drug release in order to fulfil specific objectives. Hence, characterizations of nanocarriers are very critical to control their desired in vitro and in vivo behaviour. Nanocarriers are characterized by their size, morphology and surface charge, using highly advanced microscopic techniques as scanning electron microscopy, transmission electron microscopy and atomic force microscopy. Surface morphology and size are measured by electron microscopy while dynamic light scattering and photon-correlation spectroscopy are used to determine the particle size and size distribution. Colloidal stability is ascertained through zeta potential which is an indirect measure of the surface charge and differential scanning calorimetry is used to characterize particles and drug interaction. Further, binding and internalization of targeted carriers to the specific cells could be determined by cell uptake study. Biodistribution study of targeted nanocarriers is carried out and intracellular uptake and subcellular localization of the nanocarrier could be confirmed using confocal microscopy. This review covers all the aforementioned aspect related to in vitro and in vivo characterization of pharmaceutical nanocarriers.

<p>Optimized Nanostructured Lipid Carriers Integrated into In Situ Nasal Gel for Enhancing Brain Delivery of Flibanserin</p>

“…The particle size is a crucial parameter for nanocarriers, as it has a significant impact on its biopharmaceutical characteristics including release pattern, absorption, and distribution in the biological system. 39 The measured particle size ranged from 65±0.98 to 287±4.45 nm indicating that the prepared NLCs were within the nano-size range ( Table 2). In addition, the small standard deviation obtained indicates the homogeneity of the dispersions.…”

Polymeric Nanoparticles: Production, Characterization, Toxicology and Ecotoxicology

“…Many properties of nanoparticles that may cause unexpected toxicities are equally interesting [111]. In order to prove a nanoparticle's toxicity profile and response on the suitable animal model-a model that closely represents the pathophysiology of human disorder-preliminary effectiveness in vitro followed by in vivo tests should be analyzed [112].…”

“…The special properties and features, such as size, surface charge, hydrophilicity and hydrophobicity, or even type of polymer, govern the potential application of polymeric NPs [112,114]. Importantly, the content of alcohols, amines and thiols provides a successful polymer functionalization.…”

Nanopolyphenols: a review of their encapsulation and anti-diabetic effects

“…electrospun and electrosprayed nanocarriers) and also based on their composition as outlined in Fig. 4 [52,53]. The use of inorganic nanomaterials such as silica, gold and carbon-based nanostructures are being used extensively for drug delivery in cancer therapy [54].…”